Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Apar K, Ganti"'
Autor:
Parvez Khan, Jawed Akhtar Siddiqui, Prakash G. Kshirsagar, Ramakanth Chirravuri Venkata, Shailendra Kumar Maurya, Tamara Mirzapoiazova, Naveenkumar Perumal, Sanjib Chaudhary, Ranjana Kumari Kanchan, Mahek Fatima, Md Arafat Khan, Asad Ur Rehman, Imayavaramban Lakshmanan, Sidharth Mahapatra, Geoffrey A. Talmon, Prakash Kulkarni, Apar K. Ganti, Maneesh Jain, Ravi Salgia, Surinder Kumar Batra, Mohd Wasim Nasser
Publikováno v:
Molecular Cancer, Vol 22, Iss 1, Pp 1-22 (2023)
Abstract Background Small cell lung cancer (SCLC) is an aggressive lung cancer subtype that is associated with high recurrence and poor prognosis. Due to lack of potential drug targets, SCLC patients have few therapeutic options. MicroRNAs (miRNAs) p
Externí odkaz:
https://doaj.org/article/70ed0bb8d596449cab613722670a3e36
Autor:
Sushanta Halder, Soumi Basu, Shobhit Lall, Apar K. Ganti, Surinder K. Batra, Parthasarathy Seshacharyulu
Publikováno v:
Expert Opinion on Therapeutic Targets.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1e729b866a371499906beea0f2488dc2
https://doi.org/10.1080/14728222.2023.2218613
https://doi.org/10.1080/14728222.2023.2218613
Autor:
Parvez Khan, Jawed A Siddiqui, Prakash G. Kshirsagar, Ramakanth Chirravuri Venkata, Shailendra Kumar Maurya, Tamara Mirzapoiazova, Naveenkumar Perumal, Sanjib Chaudhary, Ranjana Kanchan, Mahek Fatima, Md Arafat Khan, Asad Ur Rehman, Imayavaramban Lakshmanan, Sidharth Mahapatra, Geoffrey A. Talmon, Prakash Kulkarni, Apar K Ganti, Maneesh Jain, Ravi Salgia, Surinder Kumar Batra, Mohd Wasim Nasser
Publikováno v:
Molecular cancer. 22(1)
Background Small cell lung cancer (SCLC) is an aggressive lung cancer subtype that is associated with high recurrence and poor prognosis. Due to lack of potential drug targets, SCLC patients have few therapeutic options. MicroRNAs (miRNAs) provide an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5619d298cdd60c2957ebd529bff5cbf3
https://pubmed.ncbi.nlm.nih.gov/36597126
https://pubmed.ncbi.nlm.nih.gov/36597126
Autor:
Shailendra K. Gautam, Parvez Khan, Gopalakrishnan Natarajan, Pranita Atri, Abhijit Aithal, Apar K. Ganti, Surinder K. Batra, Mohd W. Nasser, Maneesh Jain
Publikováno v:
Cancers. 15:1640
Early detection significantly correlates with improved survival in cancer patients. So far, a limited number of biomarkers have been validated to diagnose cancers at an early stage. Considering the leading cancer types that contribute to more than 50
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8651465bab840f7040937d266430f84b
https://doi.org/10.3390/cancers15061640
https://doi.org/10.3390/cancers15061640
Publikováno v:
American Society of Clinical Oncology Educational Book. :176-183
Scientific investigation is extremely active in the treatment, management, and optimization of therapies for patients with head and neck cancer. These issues have undergone recent rapid evolution in response to a changing epidemiology based on an inc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92a9e4ef8608d1626e108d951a2f6561
https://doi.org/10.1200/edbk_161309
https://doi.org/10.1200/edbk_161309
Autor:
Ezra E W Cohen, Denis Soulières, Christophe Le Tourneau, José Dinis, Lisa Licitra, Myung-Ju Ahn, Ainara Soria, Jean-Pascal Machiels, Nicolas Mach, Ranee Mehra, Barbara Burtness, Pingye Zhang, Jonathan Cheng, Ramona F Swaby, Kevin J Harrington, Mirelis Acosta-Rivera, Douglas R. Adkins, Morteza Aghmesheh, Mario Airoldi, Eduardas Aleknavicius, Yousuf Al-Farhat, Alain P. Algazi, Salah Almokadem, Anna Alyasova, Jessica R. Bauman, Marco Benasso, Alfonso Berrocal, Victoria Bray, Barbara Ann Burtness, Francesco Caponigro, Ana Castro, Terrence P. Cescon, Kelvin Chan, Arvind Chaudhry, Bruno Chauffert, Ezra Cohen, Tibor Csoszi, J.P. De Boer, Jean-Pierre Delord, Andreas Dietz, Jose Dinis, Charlotte Dupuis, Laurence Digue, Jozsef Erfan, Yolanda Escobar Alvarez, Mererid Evans, Mary Jo Fidler, Martin David Forster, Signe Friesland, Apar K. Ganti, Lionnel Geoffrois, Cliona Grant, Viktor Gruenwald, Kevin Harrington, Thomas Hoffmann, Geza Horvai, Arturas Inciura, Raymond Jang, Petra Jankowska, Antonio Jimeno, Mano Joseph, Alejandro Juarez Ramiro, Boguslawa Karaszewska, Andrzej Kawecki, Ulrich Keilholz, Ulrich Keller, Sung-Bae Kim, Judit Kocsis, Nuria Kotecki, Mark F. Kozloff, Julio Lambea, Laszlo Landherr, Yuri Lantsukhay, Sergey Alexandrovich Lazarev, Lip Way Lee, Igor Dmitrievich Lifirenko, Danko Martincic, Oleg Vladmirovhich Matorin, Margaret McGrath, Krzysztof Misiukiewicz, John C. Morris, Fagim Fanisovich Mufazalov, Jiaxin Niu, Devraj Pamoorthy Srinivasan, Pedro Perez Segura, Daniel Rauch, Maria Leonor Ribeiro, Cristina Rodriguez, Frederic Rolland, Antonio Russo, Agnes Ruzsa, Frederico Sanches, Sang-Won Shin, Mikhail Shtiveland, Denis Soulieres, Pol Specenier, Eva Szekanecz, Judit Szota, Carla M.L. van Herpen, Hector A. Velez-Cortes, William V. Walsh, Stefan Wilop, Ralph Winterhalder, Marek Wojtukiewicz, Deborah Wong, Dan Zandberg
Publikováno v:
The Lancet, Vol. 393, No 10167 (2019) pp. 156-167
The lancet : international edition
Lancet, Vol. 393, no. 10167, p. 156-167 (2019)
The lancet : international edition
Lancet, Vol. 393, no. 10167, p. 156-167 (2019)
Summary Background There are few effective treatment options for patients with recurrent or metastatic head-and-neck squamous cell carcinoma. Pembrolizumab showed antitumour activity and manageable toxicity in early-phase trials. We aimed to compare
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2fa1f3e2ce98a5be2c51dc208c21406
https://archive-ouverte.unige.ch/unige:155811
https://archive-ouverte.unige.ch/unige:155811
Autor:
Bryant R, England, Jeremy, Sokolove, William H, Robinson, Geoffrey M, Thiele, Apar K, Ganti, Harlan, Sayles, Kaleb, Michaud, Liron, Caplan, Lisa A, Davis, Grant W, Cannon, Brian, Sauer, Namrata, Singh, E, Blair Solow, Andreas M, Reimold, Gail S, Kerr, Pascale, Schwab, Josh F, Baker, Ted R, Mikuls
Publikováno v:
Arthritisrheumatology (Hoboken, N.J.). 68(10)
To examine the potential of circulating cytokines and chemokines as biomarkers of cancer mortality risk in patients with rheumatoid arthritis (RA).Male participants in the Veterans Affairs RA registry were followed up from the time of enrollment unti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::bd5fff953365aa017c04ab53ae102a29
https://pubmed.ncbi.nlm.nih.gov/27111000
https://pubmed.ncbi.nlm.nih.gov/27111000
Publikováno v:
Cancer. 120(13)
Despite clinical trials demonstrating improved survival with adjuvant chemotherapy (AC) for patients with American Joint Committee on Cancer stages I to III non-small cell lung cancer (NSCLC), it is unclear whether this survival benefit extends to br
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::92447ad0464858f828efde59d34aef31
https://pubmed.ncbi.nlm.nih.gov/24668613
https://pubmed.ncbi.nlm.nih.gov/24668613
Autor:
Wilson I, Gonsalves, Swapna, Kanuri, Tsewang, Tashi, Ibrahim, Aldoss, Ashwin, Sama, Islam, Al-Howaidi, Ashwin, Ganta, Mudappa, Kalaiah, Ramya, Thota, Jairam, Krishnamurthy, Xiang, Fang, Peter, Townley, Apar K, Ganti, Shanmuga, Subbiah, Peter T, Silberstein
Publikováno v:
Journal of surgical oncology. 104(6)
A long-term determinant of survival in resectable colon cancer is the involvement of regional lymph nodes. We evaluated the clinicopathologic factors associated with lymph node retrieval.We conducted a retrospective analysis of patients with resected
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::928a41f9c4de1daa60e2e3137d2d7c9c
https://pubmed.ncbi.nlm.nih.gov/21337344
https://pubmed.ncbi.nlm.nih.gov/21337344